Most Common Side Effects of Ozempic
Ozempic (semaglutide) causes gastrointestinal issues in most patients using it for weight loss off-label or via Wegovy (higher-dose version for obesity). Clinical trials and post-marketing data show these as the top reported effects, often mild to moderate and decreasing over time.[1][2]
- Nausea (up to 44% of users)
- Diarrhea (up to 30%)
- Vomiting (up to 25%)
- Constipation (up to 24%)
- Abdominal pain (up to 20%)
- Headache (up to 14%)
- Fatigue (up to 11%)
- Dizziness (up to 8%)
- Bloating or gas (up to 7%)
- Heartburn (up to 5%)
These occur most frequently during dose escalation; starting low (0.25 mg weekly) and titrating slowly reduces incidence.[1]
Why Do These Side Effects Happen?
Semaglutide mimics GLP-1 hormone, slowing gastric emptying and signaling fullness to the brain. This delays stomach emptying, leading to nausea, vomiting, and digestive upset. Appetite suppression aids weight loss but contributes to fatigue and low blood sugar feelings in some.[2][3]
How Long Do Side Effects Last?
Most peak in the first 4-8 weeks, improving as the body adjusts. Nausea often resolves within days of each dose increase. About 5-10% discontinue due to persistent issues.[1][4] Taking on an empty stomach or with anti-nausea meds like ondansetron helps.
What If Side Effects Are Severe?
Seek medical help for dehydration from vomiting/diarrhea, severe abdominal pain (possible pancreatitis risk), or vision changes (thyroid tumor warning). Rare but serious: gallbladder issues (cholecystitis in 1-2%), kidney problems, or allergic reactions.[2][5] No increased suicidal ideation risk per FDA reviews.[3]
Differences Between Ozempic and Wegovy for Weight Loss
Ozempic (max 2 mg weekly, diabetes-approved) and Wegovy (up to 2.4 mg, obesity-approved) share identical side effects profile at equivalent doses. Wegovy trials report slightly higher GI rates due to higher dosing, but same management applies. Both carry boxed warning for thyroid C-cell tumors from rodent studies.[1][6]
Patient Tips to Manage Side Effects
Eat smaller, bland meals; avoid fatty/spicy foods; stay hydrated; use ginger or OTC antacids. Injectable form (subcutaneous weekly) minimizes peaks vs. oral semaglutide (Rybelsus).[4] Weight loss averages 15% body weight over 68 weeks, but monitor for muscle loss or nutrient gaps.[7]
Less Common but Notable Risks
Hypoglycemia (if combined with insulin/sulfonylureas), injection-site reactions (2-5%), or hair thinning (temporary, from rapid weight loss). Long-term data limited; ongoing trials track cardiovascular benefits outweighing risks for eligible patients.[3][5]
[1]: Novo Nordisk Ozempic Prescribing Information (2023) - link
[2]: FDA Ozempic Label - link
[3]: STEP Trials (NEJM, 2021) - link
[4]: Mayo Clinic Semaglutide Overview - link
[5]: Drugs.com Ozempic Side Effects - link
[6]: Wegovy Prescribing Information - link
[7]: Lancet Diabetes Study (2022) - link